WallStreetZenWallStreetZen

NASDAQ: NBIX
Neurocrine Biosciences Inc Stock Ownership - Who owns Neurocrine Biosciences?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Neurocrine Biosciences Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Eric BenevichChief Commercial Officer2024-04-1512,587$81.05
$1.02MBuy
Eric BenevichChief Commercial Officer2024-04-1512,587$133.37
$1.68MSell
Eric BenevichChief Commercial Officer2024-04-157,231$81.49
$589.25kBuy
Eric BenevichChief Commercial Officer2024-04-157,231$133.37
$964.36kSell
Ingrid DelaetChief Regulatory Officer2024-04-01272$79.02
$21.49kBuy
Ingrid DelaetChief Regulatory Officer2024-04-01272$137.30
$37.35kSell
Ingrid DelaetChief Regulatory Officer2024-03-215,000$145.06
$725.32kSell
Ingrid DelaetChief Regulatory Officer2024-03-215,000$103.52
$517.60kBuy
Eric BenevichChief Commercial Officer2024-03-1469,521$81.05
$5.63MBuy
Eric BenevichChief Commercial Officer2024-03-145,479$79.02
$432.95kBuy

1 of 16

NBIX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NBIX insiders and whales buy or sell their stock.

NBIX Shareholders

What type of owners hold Neurocrine Biosciences Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Bvf Partners L P35.23%35,058,600$4.67BInsider
Blackrock Inc13.72%13,647,891$1.82BInstitution
Vanguard Group Inc9.76%9,710,328$1.29BInstitution
State Street Corp4.08%4,063,336$541.36MInstitution
Bellevue Group Ag2.44%2,430,500$323.82MInstitution
Morgan Stanley2.34%2,326,294$309.93MInstitution
Renaissance Technologies LLC2.00%1,988,546$264.93MInstitution
Jpmorgan Chase Co1.74%1,735,543$231.23MInstitution
Geode Capital Management LLC1.63%1,623,124$216.25MInstitution
Janus Henderson Group PLC1.56%1,551,367$206.69MInstitution

1 of 3

NBIX vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NBIX69.67%30.33%Net SellingNet Selling
VTRS80.70%17.91%Net SellingNet Selling
TEVA51.71%0.97%Net SellingNet Selling
RDY14.05%0.00%
CTLT79.66%20.34%Net BuyingNet Selling
View Top Pharmaceutical Stocks

Neurocrine Biosciences Stock Ownership FAQ

Who owns Neurocrine Biosciences?

Neurocrine Biosciences (NASDAQ: NBIX) is owned by 92.59% institutional shareholders, 40.30% Neurocrine Biosciences insiders, and 0.00% retail investors. Bvf Partners L P is the largest individual Neurocrine Biosciences shareholder, owning 35.06M shares representing 35.23% of the company. Bvf Partners L P's Neurocrine Biosciences shares are currently valued at $4.65B.

If you're new to stock investing, here's how to buy Neurocrine Biosciences stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.